FLUOPTICS Part of Getinge
Entity

  • FLUOPTICS Part of Getinge

    Created in 2009


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    485 2,771

  • Activities

    deeptech biotech

  • Entity types

    Startup

  • Location

    44 Rue des Berges, 38000 Grenoble, France

    Grenoble

    France

  • Employees

    Scale: 11-50

    Estimated: 26

  • SIREN

    510508716

  • Engaged corporates

    5
    6 1

  • Added in Motherbase

    6 years, 6 months ago
Description
  • Value proposition

    Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery.

    Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red molecular probes AngioStampTM for tumors and angiogenesis, and SentiDyeTM for vascular networks and lymphatic drainage. The instrument, as well as the probes, helps in understanding disease mechanisms and in developing new therapies.

    Fluorescence imaging solutions

  • Original language

    Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery.

    Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red molecular probes AngioStampTM for tumors and angiogenesis, and SentiDyeTM for vascular networks and lymphatic drainage. The instrument, as well as the probes, helps in understanding disease mechanisms and in developing new therapies.

Corporate interactions
Corporate TypeTweets Articles
Assurance Maladie
Assurance Maladie
Insurance, Government Administration
Assurance Maladie
Insurance, Government Administration 		Other

5 Oct 2019


MEDICALPS
MEDICALPS
Business Consulting and Services
MEDICALPS
Business Consulting and Services 		Other

17 Jan 2023


UGAP
UGAP
National and local authorities, Government Administration
UGAP
National and local authorities, Government Administration 		Not capitalistic
Partnership
Event

6 Sep 2017


CEA
CEA
Research
CEA
Research 		Other

25 Feb 2021


Minalogic
Minalogic
Public business cluster, French Cluster, IT Services and IT Consulting
Minalogic
Public business cluster, French Cluster, IT Services and IT Consulting 		Other

14 Oct 2016


Similar entities
Last news
Show all articles
Social network dynamics